Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.

Inadequate hemodialysis was a major cause of erythropoietin resistance in pediatric patients. Investigators have identified several risk factors associated with erythropoietin (EPO) resistance in ...

Absence of progression correctly identified by subsequent MRI in nearly 95, 90, 70 percent of men with grade group 0, 1, 2, respectively. (HealthDay News) — Use of magnetic resonance imaging ...

Program includes review of existing chemicals, developing final, systematic process for postmarket review. (HealthDay News) — Last week, the U.S. Food and Drug Administration announced a move to ...

After adjustment for demographic and health variables, hazard ratio was 1.94 for individuals with epilepsy and sleep deprivation. (HealthDay News) — Older adults with sleep deprivation and ...

Risk for MACE lower in adult-onset T1D versus T2D, but mortality higher from diabetic coma or ketoacidosis. (HealthDay News) — Adult-onset type 1 diabetes (T1D) is associated with an increased ...

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.

Among patients with baseline HbA1c of at least 8%, phone telemedicine but not video telemedicine was associated with worse glycemic control. Higher rates of telemedicine conducted by phone are ...

Former President Joe Biden revealed that he has been diagnosed with prostate cancer on Friday. Biden, age 82 years, complained of urinary symptoms, which his doctors determined to be a prostate ...

Order expected to affect specific medications covered under Medicare that are administered in a health care setting.

Compared with nonuse, GLP-1RA and thiazolidinedione combination therapy reduced risks for all-cause and cardiovascular mortality in type 2 diabetes. The combination of a glucagon-like peptide 1 ...

The average number of industry-funded oncology trials started per month fell 23.8%. Researchers have observed a decline in industry-sponsored post-approval clinical trials since the Inflation ...